Dr. Hania Kassem, MD

Dr. Kassem practices at St. Luke's Health - Sugar Land Hospital in Sugarland, Texas, part of CommonSpirit Health.

Dr. Kassem's NPI, 1881887685, was assigned on August 24, 2007. Dr. Kassem graduated from American University of Beirut Faculty of Medicine in 2005. Dr. Kassem's Texas license number on file is Q4999.

Dr. Kassem's primary practice is St. Luke's Health - Sugar Land Hospital, at 1317 Lake Pointe Parkway, Sugarland, TX 77478 in Fort Bend County. The practice phone is (281) 637-7000.

Dr. Kassem's primary practice is St. Luke's Health - Sugar Land Hospital in Sugarland, Texas, part of CommonSpirit Health. Dr. Kassem is also affiliated with Harris Health Ben Taub Hospital. The medical group on file is Baylor Medicine. Dmand AI also links Dr. Kassem to 2 more medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kassem practices, 2 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Kassem's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dr. Kassem is board certified in nephrology by the American Board of Internal Medicine. Dmand AI has Dr. Kassem's licenses on file in 3 states: Texas, Indiana and Kentucky.

Dmand AI lists acute kidney failure and chronic kidney disease among the conditions Dr. Kassem treats.

CMS data shows 52 Medicare services from Dr. Kassem across 1 procedure code in 2024, for 27 Medicare patients. Medicare paid $4,910 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 27 Medicare patients who saw Dr. Kassem in 2024. The largest group is 65 to 74, with 13 patients. 75% of them have chronic kidney disease, and 75% have diabetes. Their average risk score is 4.42, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Kassem's median patient age at 48, with 50% women.

In 2024, Dr. Kassem wrote 134 Medicare Part D claims for 57 patients. 90% of them were for generic drugs. CMS names the drug for 41 of them, across 2 drugs with 11 or more claims each, at $527 in total drug cost. In 2023, CMS named 871 claims across 26 drugs.

Dr. Kassem accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 11 papers to Dr. Kassem, published from 2008 to 2022. 2019 was the busiest year, with 2. The most frequent topics are Chromatography, High Pressure Liquid, Kidney Failure, Chronic and Renal Dialysis. Dr. Kassem's most frequent co-authors are Khaled Fouad Chatila, MD, Marjan Afrouzian, MD and John Badalamenti, MD.

CMS Open Payments shows 8 general payments to Dr. Kassem from 5 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Mallinckrodt Hospital Products Inc. paid the most, $222.

Dr. Kassem graduated from American University of Beirut Faculty of Medicine in 2005.

Dr. Kassem is in network with 19 carriers, including Aetna, Elevance and United Healthcare. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.